Please login to the form below

Not currently logged in

AZ’s Imfinzi scores orphan drug status in liver cancer

AstraZeneca AZ

Company is looking to gain approval in the first-line advanced setting

Immuno-oncology, personalised medicine continues to drive pharma sector

DNANew GlobalData survey identifies key trends impacting the industry

NantKwest rockets on promising pancreatic cancer data

One patient demonstrated a complete response following treatment

Lilly ends $1.4bn deal with immuno-oncology biotech NextCure

Lilly paid $25m upfront on top of a $15m equity investment

AbbVie lauds head-to-head win for Skyrizi versus Cosentyx

AbbVie RedwoodOutperformed rival across all primary and secondary endpoints

Roche and Illumina partner on genomics for cancer diagnostics

Roche Basel SwitzerlandWill leverage genomics system to match optimal cancer treatment

BMS expands collaboration with Nektar, sending shares soaring

Bristol Myers Squibb logoAdds research programmes in an additional two cancer types

Boehringer bolsters NASH pipeline with Enleofen link-up

Agrees to pay up to €1bn for each new marketed product

Pfizer signs $507m cancer deal with Effector Therapeutics

Pfizer logoCollaboration is focused on research into evasive oncogenic target

clusterAdopting a creative IP approach towards biotech clusters

Why big pharma paradigm needs to change

Featured jobs

Subscribe to our email news alerts


Add my company Events and Exhibition Stands is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...

Latest intelligence

White Paper for download - Explaining the price of your product
In this white paper, he breaks down the pricing options available to you, shares stories from his extensive experiences, and talks you through how to better define your pricing, step-by-step....
OPEN Health expands offering with the launch of a new Learning & Development specialist team
Enhanced expertise to deliver impactful internal training programmes for healthcare clients...
Figure 1 Clarivate
The changing nature of approvals – what does the future hold?
The 2019 CMR International Pharmaceutical R&D Factbook...